Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of continuous intravenous piperacillin + tazobactam in febrile neutropenic children
2008-005131-15Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Oct 2008
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of piperacillin + tazobactam in febrile neutropenia (FN), sponsored by CHU de Lille. Primary endpoint: Serum level of piperacillin + tazobactam. Started Oct 2008; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on 2008-005131-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005131-15.